← IPO Calendar

Nureca IPO IPO

Mainline15 Feb 202117 Feb 2021
Open
15 Feb 2021
Close
17 Feb 2021
3
Allotment
Listing
Thu, Feb 25, 2021
Price Band
₹396 to ₹400
Issue Size
25,00,175 shares (agg. up to ₹100 Cr)
Lot Size
35 Shares
Listing Date
Thu, Feb 25, 2021
Latest GMP
₹75
Est. Gain
18.75%
✦ AI Insight

GMP Trend

24-02-202175Est. ₹475+18.75%
18-02-2021115Est. ₹515+28.75%
25-01-202170Est. ₹470+17.5%

Live Subscription

CategorySubscription (times)
Total19.76x

Restated Financials (₹ Cr.)

Period Ended30 Sep 202031 Mar 202031 Mar 201931 Mar 2018
Assets102.4933.8823.527.02
Total Income122.9799.4961.9820.07
Profit After Tax36.186.406.233.11
EBITDA50.019.769.144.39
NET Worth51.6514.937.951.72
Reserves and Surplus44.6514.927.941.71
Total Borrowing8.029.150.000.00
Amount in ₹ Crore

Objects of the Issue

#Issue ObjectsEst Amt (₹ Cr.)
1Funding incremental working capital requirements of our Company10.00
2General corporate purposes0.50

About Nureca IPO

Incorporated in 2016, Nureca Limited is a healthcare and wellness products distributor. The company aims to offer the best quality, durable, and innovative tools to customers to monitor chronic diseases to improve their lifestyle. The firm has a well-diversified product portfolio including Chronic Device Products, Orthopedic products, Mother and Child products, Nutrition Supplements, and Lifestyle products to meet the Indian healthcare market requirements. It is the first digital company to sell such products through its website drtust.in and other online partners i.e. e-commerce players, retailers, and distributors. Competitive strengths Diversified product portfolio. Experienced promoter and management team. Strong online distribution network. Premium quality healthcare and wellness products. + Read More

Contact Details

Nureca Ltd. Address128 Gala Number Udyog Bhavan1st Floor Sonawala LaneGoregaon (East)Mumbai, Maharashtra, 400063+91-22-49616173cs@nureca.comVisit Website